Luteolin sensitizes human 786-O renal cell carcinoma cells to TRAIL-induced apoptosis

Life Sciences

Volumn 100, Issue 2, 2014, Pages 110-117

  Ou, Yen Chuan ^a   Li, Jian Ri ^a   Kuan, Yu Hsiang ^b   Raung, Shue Ling ^a   Wang, Chung Chiang ^a   Hung, Yu Yeh ^a   Pan, Pin Ho ^c   Lu, Hsi Chi ^d   Chen, Chun Jung ^a,d,e  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^d TUNGHAI UNIVERSITY   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

FLIP; Luteolin; Renal cell carcinoma; TRAIL

Indexed keywords

FLICE INHIBITORY PROTEIN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; LUTEOLIN; PROTEIN BID; PROTEIN KINASE B; PROTEIN MCL 1; STAT3 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL SURFACE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CARCINOMA; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SENSITIZATION;

FLIP; LUTEOLIN; RENAL CELL CARCINOMA; TRAIL;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; KIDNEY NEOPLASMS; LUTEOLIN; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED;

EID: 84897062715     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.02.002     Document Type: Article

References (32)

1. Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, et al. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci 2009;1171:59-76.
2. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmcol Ther 2001;90:157-77. (Pubitemid 32913477)
3. Brooks AD, Jacobsen KM, Li W, Shanker A, Sayers TJ. Bortezomib sensitizes human renal cell carcinoma to TRAIL apoptosis through increased activation of caspase-8 in the death-inducing signaling complex. Mol Cancer Res 2010;8:729-38.
4. Cheng AC, Huang TC, Lai CS, Kuo JM, Huang YT, Lo CY, et al. Pyrrolidine dithiocarbamate inhibition of luteolin-induced apoptosis through up-regulated phosphorylation of Akt and caspase-9 in human leukemia HL-60 cells. J Agric Food Chem 2006;54:4215-21.
5. Clark PE, Polosukhina DA, Gyabaah K, Moses HL, Thorburn A, Zent R. TRAIL and interferon-α act synergistically to induce renal cell carcinoma apoptosis. J Urol 2010;184:1166-74.
6. Coppin C, Porzsolt F, Awa A, Kumpf J, Coldman A, Wilt T. Immunotherapy for advanced renal cell cancer. Cochrane D B Syst Rev 2005;1:CD001425.
7. Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, et al. STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma. Eur Urol 2013;63:745-52.
8. Ferriola PC, Cody V, Middleton E. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure activity relationships. BiochemPharmacol 1989;38:1617-24. (Pubitemid 19120080)
9. Fu J, Chen D, Zhao D, Zhao Z, Zhou J, Xu Y, et al. Luteolin induces carcinoma cell apoptosis through binding HSP90 to suppress constitutive activation of STAT3. PLoS ONE 2012;7:e49194.
10. Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M, Nakanishi R, et al. Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells. Oncogene 2005a;24:7180-9. (Pubitemid 41679280)
11. Horinaka M, Yoshida T, Shiraishi T, Nakata S, Wakada M, Nakanishi R, et al. The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells. Biochem Biophys Res Commun 2005b;333:833-8. (Pubitemid 40854234)
12. Jang JH, Lee TJ, Yang ES, Min DS, Kim YH, Kim SH, et al. Compound C sensitizes Caki renal cancer cells to TRAIL-induced apoptosis through reactive oxygen species-mediated down-regulation of c-FLIP and Mcl-1. Exp Cell Res 2010;316:2194-203.
13. Ju W, Wang X, Shi H, Chen W, Belinsky SA, Lin Y. A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol 2007;71:1381-8. (Pubitemid 46658691)
14. Juengel E, Makarevic J, Tsaur I, Bartsch G, Neison K, Haferkamp A, et al. Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo. PLoS ONE 2013;8:e53100.
15. Kim SW, Kim SJ, Park SH, Yang HJ, Kang MC, Choi YW, et al. Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK. Clin Cancer Res 2012;19:415-27.
16. Lee SJ, Noh HJ, Sung EG, Song IH, Kim JY, Kwon TK, et al. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins. Int J Oncol 2011;38:485-92.
17. Li Y, Fang H, Xu W. Recent advance in the research of flavonoids as anticancer agents. Mini-Rev Med Chem 2007;7:663-78. (Pubitemid 47099168)
18. Macher-Goeppinger S, Aulmann S, Tagscherer KE, Wagener N, Hafekamp A, Penzel R, et al. Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer. Clin Cancer Res 2009;15:650-9.
19. Neckers L. Heat shock protein 90: the cancer chaperone. J Biosci 2007;32:517-30. (Pubitemid 46708702)
20. Norian LA, Kresowik TP, Rosevear HM, James BR, Rosean TR, Lightfoot AJ, et al. Eradication of metastatic renal cell carcinoma after adenovirus-encoded TNF-related apoptosis-inducing ligand (TRAIL)/CpG immunotherapy. PLoS ONE 2012;7:e31085.
21. Ou YC, Kuan YH, Li JR, Raung SL, Wang CC, Huang YY, et al. Induction of apoptosis by luteolin involving Akt inactivation in human 786-O renal cell carcinoma cells. Evid Based Complement Alternat Med 2013;2013:109105.
22. Panner A, Murray JC, Berger MS, Pieper RO. Heat shock protein 90α recruits FLIPs to the death-inducing signaling complex and contributes to TRAIL resistance in human glioma. Cancer Res 2007;67:9482-9. (Pubitemid 47535938)
23. Rao PS, Satelli A, Moridani M, Jenkins M, Rao US. Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: involvement of cell line-specific apoptotic mechanisms. Int J Cancer 2012;130:2703-14.
24. Rini BI. Metastatic renal cell carcinoma:many treatment options, one patient. J Clin Oncol 2009;27:3225-34.
25. Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009;373:1119-32.
26. Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, et al. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. Cancer Res 2006;66:4826-34.
27. Shi R, Ong CN, Shen HM. Protein kinase C inhibition and X-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Cancer Res 2005;65:7815-23. (Pubitemid 41297257)
28. Tan ML, Ooi JP, Ismail N, Moad AI, Muhammad TS. Programmed cell death pathways and current antitumor targets. Pharm Res 2009;26:1547-60.
29. Wang X, Chen W, Zeng W, Bai L, Tesfaigzi Y, Belinsky SA, et al. Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells. Mol Cancer Res 2008;7:1156-63.
30. Woo SM, Min KJ, Kwin TK. Calyculin A causes sensitization to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by ROS-mediated down-regulation of cellular FLICE-inhibiting protein (c-FLIP) and by enhancing death receptor 4 mRNA stabilization. Apoptosis 2012;17:1223-34.
31. Wu GS. TRAIL as a target in anti-cancer therapy. Cancer Lett 2009;285:1-5.
32. Yan J, Wang Q, Zheng X, Sun H, Zhou Y, Li D, et al. Luteolin enhances TNF-related apoptosis-inducing ligand's anticancer activity in a lung cancer xenograft mouse model. Biochem Biophys Res Commun 2012;417:842-6.